<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Biocon on Bioecon</title><link>https://en.bioecon.ru/companies/biocon/</link><description>Recent content in Biocon on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 29 Jul 2026 09:52:30 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/biocon/index.xml" rel="self" type="application/rss+xml"/><item><title>Biopharmaceuticals &amp; biomedicines</title><link>https://en.bioecon.ru/technology/biopharmaceuticals-biomedicines/</link><pubDate>Wed, 24 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/biopharmaceuticals-biomedicines/</guid><description>Large-molecule therapeutics manufactured via living cells to treat complex diseases like cancer, diabetes, and autoimmune disorders.</description></item><item><title>Local manufacturing for market access</title><link>https://en.bioecon.ru/technology/local-manufacturing-for-market-access/</link><pubDate>Wed, 24 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/local-manufacturing-for-market-access/</guid><description>Contract development, technology-transfer and local-build services that establish in-country or regional biomanufacturing so a biologic or vaccine qualifies for market access, procurement preference and supply security in target jurisdictions.</description></item></channel></rss>